The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Efficacy Data for Bispecific Antibodies in RRMM
Efficacy Data for Bispecific Antibodies in RRMM
Considerations for Dosing Bispecific Antibodies
Considerations for Dosing Bispecific Antibodies
Clinical Challenges With Triple-Class or Penta-Refractory MM
Clinical Challenges With Triple-Class or Penta-Refractory MM
Integrating Bispecific Antibodies Into Clinical Practice
Integrating Bispecific Antibodies Into Clinical Practice
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
Balancing the Scales: The Complementary Roles of RCTs and RWE in Modern Healthcare
Balancing the Scales: The Complementary Roles of RCTs and RWE in Modern Healthcare
RWE Supporting CDK4/6 Inhibitor Use in HR+ Metastatic Breast Cancer
RWE Supporting CDK4/6 Inhibitor Use in HR+ Metastatic Breast Cancer
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
Real World Use of RWE in HR+ Metastatic Breast Cancer: The Oncologist Perspective
Real World Use of RWE in HR+ Metastatic Breast Cancer: The Oncologist Perspective
Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects
Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects